160. Congenital ichthyosis Clinical trials / Disease details
Clinical trials : 42 / Drugs : 71 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 112
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02113904 (ClinicalTrials.gov) | January 27, 2014 | 2/4/2014 | Clinical Trial Using Humira in Netherton Syndrome | Phase II Clinical Trial Using Humira in Netherton Syndrome | Netherton Syndrome | Drug: Adalimumab | Assistance Publique - Hôpitaux de Paris | NULL | Completed | 4 Years | N/A | All | 11 | Phase 2 | France |